cm-seminarseries (Agenda)


September 24 - 12:00 – 1:00 pm ET

Structure and Function of Mammalian SWI/SNF (BAF) Complexes in Synovial Sarcoma
Intensify Research on Drivers of Childhood Cancers
Fusion Oncoproteins in Childhood Cancer (FusOnC2) Consortium
Speaker: Cigall Kadoch, Ph.D., Dana-Farber Cancer Institute

Introduction by Dinah Singer, Ph.D., Deputy Director for Scientific Strategy and Development, NCI

October 22 - 12:00 – 1:00 pm ET

Title: TBD
Establish a Network for Direct Patient Engagement
Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network
Speakers: Cheryl Willman, M.D., University of New Mexico & Jeff Trent, Ph.D., TGen

November 19 – 12:00 – 1:00 pm ET

Lineage Plasticity and Drug Resistance in Cancer
Develop Ways to Overcome Cancer’s Resistance to Therapy
Drug Resistance and Sensitivity Network (DRSN)
Speaker: Charles Sawyers, M.D., Memorial Sloan Kettering Cancer Center

January 28 – 12:00 – 1:00 pm ET

Supporting Innovative Cancer Research Through Data Privacy
Build a National Cancer Data Ecosystem
Privacy Preserving Patient Record Linkage Software
Speaker: Bradley Malin, Ph.D., Vanderbilt University

February 25 – 12:00 – 1:00 pm ET

Understanding Treatment Tolerability in Older Patients with Advanced Cancer
Minimize Cancer Treatment’s Debilitating Side Effects
Analyzing & Interpreting Clinician and Patient Adverse Event Data to Understand Tolerability
Speaker: Supriya Mohile, M.D., University of Rochester

March 25 – 12:00 – 1:00 pm ET

Title: TBD
Generation of Human Tumor Atlases
Human Tumor Atlas Network (HTAN)
Speaker: Christina Curtis, Ph.D., Stanford University

April 22 – 12:00 – 1:00 pm ET

Updates in CAR T Cell Therapies
Create an Adult Immunotherapy Network
Immuno-Oncology Translational Network (IOTN)
Speaker: Carl June, M.D., University of Pennsylvania

May 27 – 12:00 – 1:00 pm ET

3D Projection Electrophoresis: Protein Profiling with Single-Cell Resolution
Develop New Enabling Cancer Technologies
Integration and Validation of Emerging Technologies to Accelerate Cancer Research
Speaker: Amy Herr, Ph.D., University of California, Berkeley